FTC sues pharma firms for delaying generic AndroGel
The Federal Trade Commission has filed a complaint in federal district court alleging that AbbVie Inc. and Teva Pharmaceuticals USA Inc. illegally blocked U.S. consumers’ access to generic versions of the testosterone gel AndroGel.